Managers / Q4 2019 · view latest →
Worth Venture Partners, LLC
CIK 0001696778 · 2 EXECUTIVE DRIVE, SUITE 515, FORT LEE, NJ, 07024 · 2125589017
Summary
Worth Venture Partners, LLC reported $204M in U.S.-listed holdings across 178 positions for Q4 2019.
Its largest position, Squre 0 375 03 01 22 Cvt, represents 10.9% of the portfolio.
Compared with Q3 2019, the fund opened 25 new positions and exited 38.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- US DOMESTIC · 69.0% · $141M
- Common Stock · 15.8% · $32M
- GLOBAL · 9.6% · $20M
- Other · 3.2% · $6M
- ETP · 2.5% · $5M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| WWE 3.375 12/15/23 CVT | NEW | +5.84M | 5.84M | +$16M | $16M |
| HUBS 0.250 06/01/22 CVT | NEW | +3.50M | 3.50M | +$6M | $6M |
| W 1.125 11/01/24 CVT | NEW | +4.51M | 4.51M | +$5M | $5M |
| NUVA 2.250 03/15/21 CVT | NEW | +2.76M | 2.76M | +$4M | $4M |
| ARLOARLO TECHNOLOGIES ORD | NEW | +232.8K | 232.8K | +$980,000 | $980,000 |
| CFRXEURCONTRAFECT ORD | NEW | +1.55M | 1.55M | +$960,000 | $960,000 |
| ORGOORGANOGENESIS HOLDINGS CL A ORD | NEW | +168.0K | 168.0K | +$808,000 | $808,000 |
| ALIMERA SCIENCES ORD | NEW | +99.3K | 99.3K | +$753,000 | $753,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2019
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | SQURE 0.375 03/01/22 CVT | NOTE 0.375% 3/0 | 14.40% | $29M | 10.70M |
| 2 | FWONA 1.375 10/15/23 CVT | NOTE 1.375%10/2 · NOTE 1.375%10/1 | 13.73% | $28M | 20.81M |
| 3 | CZR 5.000 10/01/24 CVT | NOTE 5.000%10/0 | 9.56% | $20M | 10.12M |
| 4 | WWE 3.375 12/15/23 CVT | NOTE 3.375%12/1 | 7.71% | $16M | 5.84M |
| 5 | ANTMX 2.750 10/15/42 CVT | NOTE 2.750%10/1 | 7.23% | $15M | 3.50M |
| 6 | NICE 1.250 01/15/24 CVT | NOTE 1.250% 1/1 | 3.94% | $8M | 4.21M |
| 7 | RTRX 2.500 09/15/25 CVT | NOTE 2.500% 9/3 · NOTE 2.500% 9/2 · NOTE 2.500% 9/1 | 3.64% | $7M | 9.38M |
| 8 | WDAY 1.500 07/15/20 CVT | NOTE 1.500% 7/1 | 3.62% | $7M | 3.65M |
| 9 | TSLA 2.000 05/15/24 CVT | NOTE 2.000% 5/1 | 3.34% | $7M | 4.50M |
| 10 | HUBS 0.250 06/01/22 CVT | NOTE 0.250% 6/0 | 2.97% | $6M | 3.50M |
| 11 | W 1.125 11/01/24 CVT | NOTE 1.125%11/2 · NOTE 1.125%11/1 · NOTE 1.125%11/0 | 2.30% | $5M | 4.51M |
| 12 | NUVA 2.250 03/15/21 CVT | NOTE 2.250% 3/1 | 1.80% | $4M | 2.76M |
| 13 | WMGI 2.250 11/15/21 CVT | NOTE 2.250%11/1 | 1.78% | $4M | 2.50M |
| 14 | CLF 1.500 01/15/25 CVT | DBCV 1.500% 1/1 | 1.66% | $3M | 2.83M |
| 15 | TDOCTELADOC HEALTH ORDhistory → | Common Stock | 1.59% | $3M | 38.8K |
| 16 | ACAD Jan0 26.0 C | Call | 1.53% | $3M | 180.6K |
| 17 | BKNG 0.350 06/15/20 CVT | NOTE 0.350% 6/1 | 0.76% | $2M | 1.00M |
| 18 | BMRNBIOMARIN PHARMACEUTICAL ORD | Common Stock | 0.73% | $1M | 17.6K |
| 19 | ONON SEMICONDUCTOR ORD | Common Stock | 0.73% | $1M | 61.0K |
| 20 | ISHARES RUSSELL 2000 ETF | RUSSELL 2000 ETF | 0.66% | $1M | 8.1K |
| 21 | NTNXNUTANIX CL A ORD | CL A | 0.60% | $1M | 39.0K |
| 22 | FLNACASSAVA SCIENCES ORD | Common Stock | 0.55% | $1M | 177.0K |
| 23 | AIRGAIRGAIN ORD | Common Stock | 0.49% | $1M | 94.4K |
| 24 | ASPNASPEN AEROGELS ORD | Common Stock | 0.46% | $943,000 | 121.6K |
| 25 | SELECT SECTOR HEALTH CARE SPDR ETF | SBI HEALTHCARE | 0.44% | $892,000 | 8.8K |
| 26 | SONIM TECHNOLOGIES ORD | Common Stock | 0.43% | $879,000 | 242.2K |
| 27 | CLFDCLEARFIELD ORD | Common Stock | 0.43% | $875,000 | 62.8K |
| 28 | DSP GROUP ORD | Common Stock | 0.41% | $843,000 | 53.6K |
| 29 | PXLWEURPIXELWORKS ORD | New Common Stock | 0.41% | $840,000 | 214.4K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $32M | 55 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $14M | 53 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $34M | 64 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $65M | 42 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $53M | 36 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $10M | 34 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $14M | 49 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $13M | 56 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $15M | 63 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $185M | 130 | Feb 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $169M | 163 | Nov 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $184M | 173 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $205M | 194 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $169M | 183 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $163M | 183 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $170M | 150 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $217M | 148 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $202M | 130 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $222M | 130 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $269M | 115 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $206M | 111 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $126M | 101 | Feb 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $122M | 220 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $204M | 220 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $162M | 198 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $204M | 178 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $175M | 193 | Nov 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $181M | 197 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $180M | 204 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $132M | 209 | Feb 15, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- DLD Asset Management, LP028-17749
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.